ROCKVILLE, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) ...
Some results have been hidden because they may be inaccessible to you